These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27055953)

  • 21. Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing.
    Knowles JW; Rader DJ; Khoury MJ
    JAMA; 2017 Jul; 318(4):381-382. PubMed ID: 28742895
    [No Abstract]   [Full Text] [Related]  

  • 22. Screening of APOB gene mutations in subjects with clinical diagnosis of familial hypercholesterolemia.
    Meriño-Ibarra E; Castillo S; Mozas P; Cenarro A; Martorell E; Díaz JL; Suárez-Tembra M; Alonso R; Civeira F; Mata P; Pocoví M;
    Hum Biol; 2005 Oct; 77(5):663-73. PubMed ID: 16596945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterozygous familial hypercholesterolemia case study.
    Friedrich DA
    J Am Acad Nurse Pract; 2010 Oct; 22(10):523-6. PubMed ID: 21040085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of early recognition of heterozygous familial hypercholesterolaemia.
    Ryan A; Byrne CD
    Curr Opin Lipidol; 2015 Aug; 26(4):298-303. PubMed ID: 26103611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Screening for familial hypercholesterolemia].
    Vandenbroucke JP
    Ned Tijdschr Geneeskd; 1996 Apr; 140(17):944-8. PubMed ID: 8676977
    [No Abstract]   [Full Text] [Related]  

  • 26. Screening for familial hypercholesterolemia: what is the most effective strategy?
    Daniels SR
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):130-1. PubMed ID: 18059381
    [No Abstract]   [Full Text] [Related]  

  • 27. Familial hypercholesterolemia: An urgent public health priority.
    Stock J
    Atherosclerosis; 2020 Sep; 308():48-49. PubMed ID: 32736795
    [No Abstract]   [Full Text] [Related]  

  • 28. Familial hypercholesterolemia in Brazil: cascade screening program, clinical and genetic aspects.
    Jannes CE; Santos RD; de Souza Silva PR; Turolla L; Gagliardi AC; Marsiglia JD; Chacra AP; Miname MH; Rocha VZ; Filho WS; Krieger JE; Pereira AC
    Atherosclerosis; 2015 Jan; 238(1):101-7. PubMed ID: 25461735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What Should Be the Screening Strategy for Familial Hypercholesterolemia?
    McCrindle BW; Gidding SS
    N Engl J Med; 2016 Oct; 375(17):1685-1686. PubMed ID: 27783919
    [No Abstract]   [Full Text] [Related]  

  • 30. Cascade screening of familial hypercholesterolemia must go on.
    Galema-Boers JM; Versmissen J; Roeters van Lennep HW; Dusault-Wijkstra JE; Williams M; Roeters van Lennep JE
    Atherosclerosis; 2015 Oct; 242(2):415-7. PubMed ID: 26282946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a motivational interviewing genetic counseling intervention to increase cascade cholesterol screening in families of children with familial hypercholesterolemia.
    Kruger V; Redlinger-Grosse K; Walters ST; Ash E; Cragun D; McCarthy Veach P; Zierhut HA
    J Genet Couns; 2019 Oct; 28(5):1059-1064. PubMed ID: 31273864
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter by Tromp et al Regarding Article, "Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland".
    Tromp TR; Hovingh GK; Reeskamp LF
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e44-e45. PubMed ID: 34936472
    [No Abstract]   [Full Text] [Related]  

  • 33. Familial hypercholesterolemia: a missed opportunity in preventive medicine.
    Watts GF; Lewis B; Sullivan DR
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):404-5. PubMed ID: 17593912
    [No Abstract]   [Full Text] [Related]  

  • 34. Response by Björnsson et al to Letter Regarding Article, "Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland".
    Björnsson E; Thorgeirsson G; Helgadóttir A; Gudbjartsson DF; Hólm H; Thorsteinsdóttir U; Sulem P; Stefánsson K
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e46-e47. PubMed ID: 34936471
    [No Abstract]   [Full Text] [Related]  

  • 35. What Is the Prevalence of Familial Hypercholesterolemia?
    Brunham LR; Hegele RA
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2629-2631. PubMed ID: 34433299
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic risk factors in the development of heart disease: familial hypercholesterolemia and hyperhomocysteinemia.
    LaCharity LA
    AACN Clin Issues; 1998 Nov; 9(4):531-8. PubMed ID: 9855863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial Hypercholesterolemia: The Most Common Monogenic Disorder in Humans.
    Kastelein JJP; Reeskamp LF; Hovingh GK
    J Am Coll Cardiol; 2020 May; 75(20):2567-2569. PubMed ID: 32439006
    [No Abstract]   [Full Text] [Related]  

  • 38. [Advantages of Universal Early Childhood Screening for Familial Hypercholesterolaemia in Germany].
    Paetow U; Kordonouri O; Schwab KO
    Klin Padiatr; 2023 Jan; 235(1):5-12. PubMed ID: 35240713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addressing Gaps in Racial/Ethnic Representation in Familial Hypercholesterolemia Registries: Implications and Recommendations for Equitable Access to Research and Care.
    Mszar R; Santos RD; Nasir K
    Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007306. PubMed ID: 33508946
    [No Abstract]   [Full Text] [Related]  

  • 40. Sex Disparities in Familial Hypercholesterolemia.
    Jiménez A; Viñals C; Marco-Benedí V; González P; Domenech M; Suárez-Tembra M; Pinto X; Ortega E
    J Am Coll Cardiol; 2023 Jan; 81(2):203-205. PubMed ID: 36631212
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.